<DOC>
	<DOCNO>NCT02153684</DOCNO>
	<brief_summary>The Canadian Respiratory Research Network ( CRRN ) recently establish study origins evolution airway disease population . The CRRN fund Institute Cardio-respiratory Health ( ICRH ) , institute CIHR . The Physiology platform support CRRN platform ( biology , imaging , population health , knowledge transfer ) provide comprehensive characterization nature extent physiological impairment respiratory function smoker risk airway disease early mild airway obstruction . The planned study physiology group ( core site locate Queen 's University , University British Columbia McGill University ) initially focus smoking-related lung injury risk COPD meeting spirometric criterion mild airway obstruction , without respiratory symptom . The primary aim initial study identify validate sensitive test ( ) peripheral airway dysfunction may qualify physiological biomarkers use future CRRN study .</brief_summary>
	<brief_title>Canadian Cohort Origin Progression Airway Disease : Physiology Platform</brief_title>
	<detailed_description />
	<criteria>INCLUSION CRITERIA : Stable patient GOLD grade 1 mild COPD include study : postbronchodilator FEV1≥80 % predict FEV1/FVC ratio &lt; 0.7 &lt; LLN ; ≥40 year age ; cigarette smoke history ≥10 packyears ≥10 year exposure inhale substance ( i.e. , second hand smoke and/or biomass ) . Symptomatic ( category B ) subject Baseline Dyspnea Index ( BDI ) total score ≤9 , modify Medical Research Council ( MRC ) dyspnea score ≥2 , COPD Assessment Test ( CAT ) score ≥10 . Asymptomatic ( category A ) subject BDI &gt; 9 , modify MRC &lt; 2 CAT &lt; 10 , history seek medical care respiratory symptom , history use respiratory medication . Symptomatic current exsmokers ( &gt; 10 packyear history ) meet criterion COPD ( e.g. , postbronchodilator FEV1 &lt; 80 % predict FEV1/FVC &lt; 0.7 , measurement also &lt; LLN ) respiratory medication include . Symptomatic define : BDI≤9 , modify MRC≥2 CAT &gt; 10 . Healthy , age sexmatched , nonsmoking ( &lt; 2 packyear history ) participant normal spirometry use comparison purpose . EXCLUSION CRITERIA : presence clinically significant comorbidities could contribute dyspnea exercise limitation ( i.e. , unstable heart disease , pulmonary disease COPD , uncontrolled diabetes , neuromuscular orthopedic impairment ) ; history/clinical evidence asthma ; contraindication exercise test ; &lt; 40 year age ; body mass index &lt; 18.5 &gt; =35 kg/m2 .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>smoking</keyword>
	<keyword>small airway dysfunction</keyword>
	<keyword>mild COPD</keyword>
	<keyword>dyspnea</keyword>
	<keyword>exercise</keyword>
	<keyword>clinical outcome</keyword>
</DOC>